Fang Shen will be joined by Xiangjun Kong to present, "Current US Regulations on Chinese Enterprises Investment or Commercial Activities," at the Lingang Special Area on Tuesday, July 30, 2024, at 1:30 - 4 p.m.
In this seminar, experienced US and Chinese law firm partners will discuss the following topics, especially regarding how these laws apply to Chinese biopharmaceutical companies’ investment, acquisition, joint venture, service activities in the US:
Topics:
- How does the CFIUS law apply to Chinese companies’ investment or joint ventures in the U.S.
- Status and proposed contents of the proposed BioSecure Act 2024
- US regulations on cross-border data transfer
Presenters
Fang Shen, Husch Blackwell LLP
Xiangjun Kong, Shiye Law Firm (China)
Location
Shiye Law Firm, Linggang Special Area, Shanghai, China
标题：现行美国监管立法对中国企业投资或商业活动的限制
在本次研讨会中，在中美投资项目中具有丰富经验的美国律所合伙人将讨论以下主题，特别是这些法律如何适用于中国生物制药公司在美国的投资、收购、合资、服务活动：
- CFIUS法如何适用于中国企业在美国的投资或合资企业
- 2024 年生物安全法案提案的现状和拟议内容
- 美国关于跨境数据传输的法规